These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12021870)

  • 1. Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene.
    Han MG; Kweon CH; Mo IP; Kim SJ
    Arch Virol; 2002 May; 147(5):1017-31. PubMed ID: 12021870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus.
    Schnitzlein WM; Winans R; Ellsworth S; Tripathy DN
    Virology; 1995 Jun; 209(2):304-14. PubMed ID: 7778265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor.
    Fuchs W; Ziemann K; Teifke JP; Werner O; Mettenleiter TC
    J Gen Virol; 2000 Mar; 81(Pt 3):627-38. PubMed ID: 10675400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Korean strains of infectious laryngotracheitis virus by nucleotide sequences and restriction fragment length polymorphism.
    Han MG; Kim SJ
    Vet Microbiol; 2001 Dec; 83(4):321-31. PubMed ID: 11600266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus.
    Pavlova SP; Veits J; Blohm U; Maresch C; Mettenleiter TC; Fuchs W
    J Gen Virol; 2010 Apr; 91(Pt 4):847-57. PubMed ID: 19940061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution and Mutagenesis of Avian Infectious Laryngotracheitis Virus from Cosmid and Yeast Centromeric Plasmid Clones.
    Spatz S; García M; Fuchs W; Loncoman C; Volkening J; Ross T; Riblet S; Kim T; Likens N; Mettenleiter T
    J Virol; 2023 Apr; 97(4):e0140622. PubMed ID: 37022163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of avian infectious laryngotracheitis virus.
    Fuchs W; Veits J; Helferich D; Granzow H; Teifke JP; Mettenleiter TC
    Vet Res; 2007; 38(2):261-79. PubMed ID: 17296156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
    Helferich D; Veits J; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2007 Mar; 88(Pt 3):732-742. PubMed ID: 17325345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM; Browning GF; Hartley CA; Gilkerson JR
    Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rescue of a recombinant Newcastle disease virus expressing the green fluorescent protein].
    Ge JY; Wen ZY; Wang Y; Bao ED; Bu ZG
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):547-51. PubMed ID: 17037052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on a live virus vaccine against infectious laryngotracheitis of chickens. I. Biological properties of attenuated strain C7.
    Izuchi T; Hasegawa A; Miyamoto T
    Avian Dis; 1983; 27(4):918-26. PubMed ID: 6316899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.
    Kirkpatrick NC; Mahmoudian A; Colson CA; Devlin JM; Noormohammadi AH
    Avian Pathol; 2006 Dec; 35(6):449-53. PubMed ID: 17121733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycoprotein I- and glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells.
    Devlin JM; Browning GF; Gilkerson JR
    Arch Virol; 2006 Jul; 151(7):1281-9. PubMed ID: 16502283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability of a Newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos.
    Yu Q; Li Y; Dimitrov K; Afonso CL; Spatz S; Zsak L
    Vaccine; 2020 Jan; 38(4):925-932. PubMed ID: 31703935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol.
    Devlin JM; Browning GF; Gilkerson JR; Fenton SP; Hartley CA
    Avian Pathol; 2008 Feb; 37(1):83-8. PubMed ID: 18202954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.